Search

Search Constraints

You searched for: Author/Creator Viswanatha, David

Search Results

1. The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS. Issue 11 (2nd October 2018)

2. Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms. (9th May 2017)

3. Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow–Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?. Issue 2 (2nd June 2018)

4. Characteristics of patients with myelodysplastic syndrome with balanced translocations. (17th March 2020)

5. Comparison between GATA2 and DDX41-mutated myeloid neoplasms. (October 2022)

6. Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance. Issue 4 (8th August 2022)

7. A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy. Issue 9 (30th June 2022)

8. A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3‐ITD mutational status. Issue 12 (17th October 2018)

10. Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort study. (February 2023)